Zimmer Biomet Holdings has named Vafa Jamali the CEO of its NewCo spinoff, which will comprise the company’s spine and dental businesses. NewCo, an independent, publicly traded company, is expected to close in mid-2022.
Most recently, Jamali served as the chief commercial officer of Rockley Photonics, where he led commercial strategic planning. Previously, he was senior vice president and president of respiratory, gastrointestinal, and informatics at Medtronic.
“Vafa’s extensive knowledge and experience in building teams, developing long-term growth strategies, prioritizing resources, driving execution, and delivering growth across the medical device industry make him the ideal leader to shape the direction of NewCo and move the business forward,” said Bryan Hanson, president and CEO of Zimmer Biomet.
“I’m so excited to join NewCo at this pivotal time in the company’s creation. This is a prime opportunity to leverage my experience in execution and value creation for NewCo,” said Jamali.
“I am looking forward to working closely with the new team to develop and drive investment strategies and a plan for long-term growth in the spine and dental markets, all with a relentless focus on delivering for patients, customers, team members, and our future shareholders,” Jamali said.
With more than 25 years of experience in the medical device industry including 20 years in executive leadership positions, Jamali has extensive knowledge in a variety of medical device specialties, Zimmer Biomet Holdings said.
Related Articles
Zimmer Biomet to Spin Off Its Dental Business
Baird Named CEO at Henry Schein One
Global Summits Institute Names World’s Top 100 Doctors
